C. trachomatis MOMP inhibitors are a class of chemical compounds that specifically target and inhibit the major outer membrane protein (MOMP) of Chlamydia trachomatis, a bacterial pathogen. MOMP is the most abundant protein found in the outer membrane of the bacterium, playing a crucial role in the structural integrity and permeability of the membrane, as well as in facilitating interactions with the host cells. Inhibitors designed to interfere with MOMP function can disrupt these critical biological processes by binding to key regions of the protein, altering its ability to maintain membrane stability or mediate host-pathogen interactions. These inhibitors provide a powerful means of studying the molecular mechanisms by which *C. trachomatis* survives and interacts with its environment, particularly in terms of its membrane structure and function.
The development of C. trachomatis MOMP inhibitors involves an in-depth understanding of the protein's structure, including its extracellular loops and transmembrane domains, which are vital for its function. By targeting these specific regions, inhibitors can prevent the proper folding or assembly of MOMP, impairing its role in maintaining the bacterial cell's integrity. Furthermore, these inhibitors may be designed as small molecules, peptides, or other biologically derived compounds that exhibit high specificity for MOMP to minimize unintended interactions with other bacterial or host proteins. The specificity and mode of action of these inhibitors make them essential tools for researchers who aim to dissect the role of MOMP in the biology of *C. trachomatis*, contributing to a deeper understanding of bacterial membrane protein function and pathogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $63.00 | 8 | |
A peptide that disrupts the outer membrane of Gram-negative bacteria, potentially affecting MOMP integrity. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
A compound that inhibits bacterial RNA polymerase, could reduce MOMP expression by suppressing transcription. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
A macrolide compound that inhibits bacterial protein synthesis, potentially reducing MOMP levels. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
A compound that inhibits bacterial protein synthesis, could lead to decreased production of MOMP. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
A compound that inhibits protein synthesis, potentially reducing the expression of MOMP. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $84.00 | ||
A nitrofuran antibiotic that can damage bacterial DNA, possibly affecting the expression of MOMP. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
A fluoroquinolone that inhibits DNA gyrase and topoisomerase IV, potentially reducing MOMP expression. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
A compound that inhibits bacterial protein synthesis elongation factor G, potentially reducing MOMP production. | ||||||